PTC Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.About PTCT
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
PTCT Key Statistics
PTCT News
Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Hold rating on PTC Therapeutics (PTCT – Research Report). The associated price target r...
Morgan Stanley analyst Judah Frommer maintained a Buy rating on PTC Therapeutics (PTCT – Research Report) yesterday and set a price target of $70.00. Judah Fro...
William Blair analyst Sami Corwin has maintained their bullish stance on PTCT stock, giving a Buy rating on March 14. Sami Corwin has given his Buy rating due...
Analyst ratings
53%
of 15 ratingsMore PTCT News
PTC Therapeutics ( (PTCT) ) has issued an announcement. On March 28, 2025, PTC Therapeutics announced that the European Commission adopted the negative opinion...
The European Commission (EC) adopted the opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) not to rene...